Open Access

Are there more NVAF patients that would benefit from anticoagulation with a NOAC?

Topic: Atrial fibrillation (AF)
Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Congress Session

About the speaker

Doctor Jeff Healey

Population Health Research Institute, Hamilton (Canada)
13 presentations
0 follower

5 more presentations in this session

Improving patient care with NOACs – Where are we now?

Speaker: Doctor F. Andreotti (Rome, IT)

Thumbnail

Thrombosis versus bleeding risk in NVAF patients – From trials to clinical practice.

Speaker: Professor G. Lip (Liverpool, GB)

Thumbnail

Oral anticoagulation – Managing challenging patients with NVAF.

Speaker: Professor H. Darius (Berlin, DE)

Thumbnail

Can evidence from VTE treatment trials with NOACs inform the cardiologist?

Speaker: Doctor A. Cohen (London, GB)

Thumbnail

Optimising patient care with NOACs – Panel discussion.

Speaker: Professor H. Darius (Berlin, DE) Doctor F. Andreotti (Rome, IT)

Thumbnail

Access the full session

Oral anticoagulation, thrombosis and bleeding – Improving patient care with NOACs

Speakers: Doctor J. Healey, Doctor F. Andreotti, Professor G. Lip, Professor H. Darius, Doctor A. Cohen...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk